Toggle navigation
Home
Search
Services
Blog
Contact
About
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J.
Leukosite, Inc., Cambridge, MA, United States
Search 4 grants from Michael Briskin
Search grants from Leukosite, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targeting of Genes in the Mammalian Genome
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
Outcomes of Cx26 Testing in Deaf/Hard of Hearing Adults
Imaging Tool for Gene Expression in Mice
CC* Team: Oregon Big Data Research and Education Team
Recently added grants:
Integrative Structural and Functional Characterization of Tip-Link Cadherins Deafness
Vestibular Oriented Research Meetings
Mechanisms of chromatin remodeling at RNA polymerase II promoters
Function and RNA-mediated regulation of SCMH1 in Polycomb repression
Characterizing the (epi)genetics of oxytocin response in clinical and animal models
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DK049883-02
Application #
2016997
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1995-06-15
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Leukosite, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1997
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
NIH 1996
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
Comments
Be the first to comment on Michael Briskin's grant